Want to see AU:NOL full AI Analyst Report?
Top Page
NobleOak Life Ltd
(Sydney:NOL)
Select Model
Select Model
Rating:62Neutral
Price Target:
AU$1.50
▲(15.38% Upside)
Action:Reiterated
Date:01/04/26
The score is driven primarily by solid financial fundamentals—strong recent cash generation and very low leverage—tempered by highly volatile revenue and uneven profitability. Technical signals are slightly negative with the stock trading below key moving averages, while valuation appears moderate based on the P/E.
Positive Factors
Conservative balance sheet
Very low leverage and sizable equity provide durable financial flexibility for an insurer. A debt-to-equity around 0.05 and A$88.9M equity support solvency buffers, capacity to absorb adverse claims or invest in growth, and reduce refinancing risk over the medium term.
Negative Factors
Revenue volatility
Large swings in revenue and margins weaken predictability of underwriting results and cashflows. For a life insurer, volatility complicates pricing, capital modelling and reinsurance decisions, increasing the risk of earnings shocks and conservative reserving that can constrain returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Very low leverage and sizable equity provide durable financial flexibility for an insurer. A debt-to-equity around 0.05 and A$88.9M equity support solvency buffers, capacity to absorb adverse claims or invest in growth, and reduce refinancing risk over the medium term.
Read all positive factors
NobleOak Life Ltd (NOL) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$111.17M
Dividend YieldN/A
Average Volume (3M)19.05K
Price to Earnings (P/E)21.4
Beta (1Y)0.23
Revenue Growth19.44%
EPS Growth-63.67%
CountryAU
Employees3
SectorFinancial
Sector Strength70
IndustryInsurance - Life
Share Statistics
EPS (TTM)0.06
Shares Outstanding93,028,660
10 Day Avg. Volume14,036
30 Day Avg. Volume19,047
Financial Highlights & Ratios
PEG Ratio-0.69
Price to Book (P/B)1.57
Price to Sales (P/S)1.13
P/FCF Ratio2.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.24
Revenue Forecast (FY)AU$597.33M
NobleOak Life Ltd Business Overview & Revenue Model
Company Description
NobleOak Life Limited engages in underwriting life insurance products in Australia. It offers life, income protection, total and permanent disability, death, trauma, business expenses, and self-managed super fund insurance plans. The company sells...
How the Company Makes Money
NobleOak makes money primarily by underwriting and distributing life insurance policies and earning a margin between (a) the premiums it collects from policyholders and (b) the costs it incurs to provide that cover. Key revenue and earnings driver...
NobleOak Life Ltd Financial Statement Overview
Summary
Income Statement
57
Neutral
Balance Sheet
74
Positive
Cash Flow
71
Positive
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 315.95M | 123.99M | 386.65M | 343.40M | 75.43M | 61.32M |
| Gross Profit | 315.95M | 123.99M | 50.26M | 181.86M | 169.78M | 61.32M |
| EBITDA | 13.70M | 17.50M | 20.33M | 18.67M | 4.22M | 8.52M |
| Net Income | 5.18M | 7.12M | 9.28M | 7.99M | 1.69M | 4.90M |
Balance Sheet | ||||||
| Total Assets | 600.63M | 567.29M | 463.73M | 251.15M | 121.08M | 72.62M |
| Cash, Cash Equivalents and Short-Term Investments | 66.22M | 85.55M | 63.96M | 30.26M | 30.26M | 31.41M |
| Total Debt | 8.43M | 4.58M | 5.26M | 5.83M | 556.00K | 1.46M |
| Total Liabilities | 505.13M | 478.36M | 392.33M | 131.31M | 9.45M | -12.00M |
| Stockholders Equity | 95.50M | 88.94M | 71.41M | 119.84M | 111.63M | 84.62M |
Cash Flow | ||||||
| Free Cash Flow | 49.80M | 58.63M | 44.02M | 129.66M | 23.49M | -2.17M |
| Operating Cash Flow | 49.97M | 58.74M | 44.42M | 130.14M | 27.98M | -720.00K |
| Investing Cash Flow | -60.57M | -45.59M | -29.86M | -108.81M | -53.33M | -10.37M |
| Financing Cash Flow | 419.00K | 8.44M | -1.01M | -1.18M | 23.77M | 14.42M |
NobleOak Life Ltd Technical Analysis
Negative
1.30
Price Trends
1.25
Negative
1.27
Negative
1.36
Negative
Market Momentum
-0.01
Positive
46.08
Neutral
27.03
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NOL, the sentiment is Negative. The current price of 1.3 is above the 20-day moving average (MA) of 1.24, above the 50-day MA of 1.25, and below the 200-day MA of 1.36, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 46.08 is Neutral, neither overbought nor oversold. The STOCH value of 27.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:NOL.
NobleOak Life Ltd Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | AU$7.18B | 15.86 | 11.51% | 3.10% | -9.16% | 234.45% | |
62 Neutral | AU$111.17M | 21.42 | 5.62% | ― | 19.44% | -63.67% | |
60 Neutral | AU$3.72B | 17.57 | 11.69% | 2.95% | 11.02% | 62.95% | |
56 Neutral | AU$380.50M | 430.00 | 0.24% | ― | 12.63% | -90.91% | |
49 Neutral | AU$6.76B | 63.76 | 19.71% | 0.57% | 25.05% | 79.97% | |
44 Neutral | AU$4.05B | 31.71 | 3.56% | 1.65% | -14.25% | -25.71% |
* Financial Sector Average
AU:NOL
NobleOak Life Ltd
1.20
-0.21
-15.25%
AU:AMP
AMP
1.67
0.22
15.54%
AU:AUB
AUB Group
28.46
-4.50
-13.65%
AU:CGF
Challenger
10.58
2.82
36.39%
AU:HUB
HUB24 Limited
82.89
-10.89
-11.61%
AU:CVW
Clearview Wealth Limited
0.65
0.19
40.22%
NobleOak Life Ltd Corporate Events
NobleOak expects reduced exposure after securing Victorian stamp duty relief
Jul 5, 2026
NobleOak Life Limited, a long-established Australian life insurer, has evolved from its benevolent society roots into a modern provider of direct-to-consumer and white‑labelled life insurance products. Its strategy centres on delivering comp...
NobleOak lifts Embedded Value and hits FY26 in-force premium target
Jun 21, 2026
NobleOak Life Limited, an Australian direct life insurer with a long heritage, operates a digital-first, direct-to-consumer model complemented by white-labelled products for partners distributed via advisers. The company focuses on providing compe...
NobleOak Director Increases Indirect Shareholding via Superannuation Fund
May 11, 2026
NobleOak Life Limited reported a change in the indirect shareholding of director Andrew Crawfurd Gale, reflecting an on-market purchase of additional ordinary shares through a custodial arrangement. His beneficial interest, held via the Gale Famil...
NobleOak Director Anthony Brown Increases Shareholding via On‑Market Purchase
Apr 22, 2026
NobleOak Life Limited has disclosed a change in the interests of director Anthony Ross Brown, who increased his holding in the company through an on‑market purchase of 4,394 fully paid ordinary shares for a total consideration of $5,360.68. ...
NobleOak Director Anthony Brown Increases Shareholding via On-Market Purchase
Apr 17, 2026
NobleOak Life Limited has reported a change in the interests of director Anthony Ross Brown in the company’s ordinary shares. Brown holds both direct and indirect interests, with indirect holdings controlled through Brohok Investments Co Pty...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.